| Year |
Citation |
Score |
| 2023 |
Finan JM, Sutton TL, Dixon DA, Brody JR. Targeting the RNA-binding protein HuR in cancer. Cancer Research. PMID 37683260 DOI: 10.1158/0008-5472.CAN-23-0972 |
0.407 |
|
| 2022 |
Kuhn M, Zhang Y, Favate J, Morita M, Blucher A, Das S, Liang S, Preet R, Parham LR, Williams KN, Molugu S, Armstrong RJ, Zhang W, Yang J, Hamilton KE, ... Dixon DA, et al. IMP1/IGF2BP1 in human colorectal cancer extracellular vesicles. American Journal of Physiology. Gastrointestinal and Liver Physiology. PMID 36194131 DOI: 10.1152/ajpgi.00121.2022 |
0.418 |
|
| 2022 |
Brown SZ, McCarthy GA, Carroll JR, Di Niro R, Pelz C, Jain A, Sutton TL, Holly HD, Nevler A, Schultz CW, McCoy MD, Cozzitorto JA, Jiang W, Yeo CJ, Dixon DA, et al. The RNA-Binding Protein HuR Posttranscriptionally Regulates the Protumorigenic Activator YAP1 in Pancreatic Ductal Adenocarcinoma. Molecular and Cellular Biology. e0001822. PMID 35703534 DOI: 10.1128/mcb.00018-22 |
0.4 |
|
| 2022 |
Xiao H, Ye X, Vishwakarma V, Preet R, Dixon DA. CRC-derived exosomes containing the RNA binding protein HuR promote lung cell proliferation by stabilizing c-Myc mRNA. Cancer Biology & Therapy. 23: 139-149. PMID 35130122 DOI: 10.1080/15384047.2022.2034455 |
0.337 |
|
| 2020 |
Legrand N, Dixon DA, Sobolewski C. Stress granules in colorectal cancer: Current knowledge and potential therapeutic applications. World Journal of Gastroenterology. 26: 5223-5247. PMID 32994684 DOI: 10.3748/wjg.v26.i35.5223 |
0.322 |
|
| 2020 |
Dong R, Chen P, Polireddy K, Wu X, Wang T, Ramesh R, Dixon DA, Xu L, Aubé J, Chen Q. An RNA-binding protein, Hu-antigen R, in pancreatic cancer epithelial to mesenchymal transition, metastasis, and cancer stem cells. Molecular Cancer Therapeutics. PMID 32879054 DOI: 10.1158/1535-7163.Mct-19-0822 |
0.511 |
|
| 2020 |
Schultz CW, Preet R, Dhir T, Dixon DA, Brody JR. Understanding and targeting the disease-related RNA binding protein human antigen R (HuR). Wiley Interdisciplinary Reviews. Rna. e1581. PMID 31970930 DOI: 10.1002/Wrna.1581 |
0.506 |
|
| 2020 |
Brown SZ, Schultz CW, Nevler A, Li T, Jain A, O’Neil R, Jiang W, Londin E, Dixon DA, Xu L, Yeo CJ, Brody JR. Abstract B45: A feedback gene regulatory mechanism between YAP1 and the RNA-binding protein, Human Antigen R (HuR), in pancreatic cancer cells: Implications for a context-dependent pancreatic cancer cell survival network Molecular Cancer Research. 18. DOI: 10.1158/1557-3125.Hippo19-B45 |
0.563 |
|
| 2020 |
Wu X, Wei L, Gardashova G, Zhong C, Lan L, Zhang Q, Dixon DA, Welch DR, Aubé J, Xu L. Abstract P5-05-09: Chemo-sensitization of triple negative breast cancer by targeting RNA-binding protein HuR Cancer Research. DOI: 10.1158/1538-7445.Sabcs19-P5-05-09 |
0.377 |
|
| 2020 |
Andres SF, Preet R, Zhang W, Yang J, Das S, Chatterji P, Liang S, Rodriguez H, Moreira L, Shah P, Dixon DA, Guo W, Rustgi A. Su1169 RNA BINDING PROTEIN IMP1 MODULATES EXOSOME BIOLOGY IN COLON CANCER Gastroenterology. 158. DOI: 10.1016/S0016-5085(20)32018-7 |
0.42 |
|
| 2019 |
New J, Subramaniam D, Ramalingam S, Enders J, Sayed AAA, Ponnurangam S, Standing D, Ramamoorthy P, O'Neil M, Dixon DA, Saha S, Umar S, Gunewardena S, Jensen RA, Thomas SM, et al. Pleotropic role of RNA binding protein CELF2 in autophagy induction. Molecular Carcinogenesis. PMID 31020708 DOI: 10.1002/Mc.23023 |
0.474 |
|
| 2019 |
Monteleone NJ, Moore AE, Iacona JR, Lutz CS, Dixon DA. miR-21-mediated regulation of 15-hydroxyprostaglandin dehydrogenase in colon cancer. Scientific Reports. 9: 5405. PMID 30931980 DOI: 10.1038/S41598-019-41862-2 |
0.598 |
|
| 2019 |
Legrand N, Dixon DA, Sobolewski C. AU-rich element-binding proteins in colorectal cancer. World Journal of Gastrointestinal Oncology. 11: 71-90. PMID 30788036 DOI: 10.4251/Wjgo.V11.I2.71 |
0.566 |
|
| 2019 |
Wu X, Gardashova G, Lan L, Han S, Zhong C, Gowthaman R, Karanicolas J, Dixon DA, Welch DR, Li L, Ji M, Aubé J, Xu L. Abstract 1235: Targeting RNA-binding protein HuR to inhibit human breast cancer invasion and metastasis Cancer Research. 79: 1235-1235. DOI: 10.1158/1538-7445.Am2019-1235 |
0.413 |
|
| 2019 |
Andres SF, Preet R, Das S, Yang J, Chatterji P, Liang S, Mizuno R, Williams K, Moreira L, Guo W, Shah P, Dixon DA, Rustgi A. 854 – Rna Binding Protein Imp1 Promotes Exosome Production in Colon Cancer Gastroenterology. 156: S-188. DOI: 10.1016/S0016-5085(19)37263-4 |
0.421 |
|
| 2018 |
Brody JR, Dixon DA. Complex HuR function in pancreatic cancer cells. Wiley Interdisciplinary Reviews. Rna. PMID 29452455 DOI: 10.1002/Wrna.1469 |
0.411 |
|
| 2018 |
Iwakuma T, Parrales A, McDonald P, Roy A, Braun MW, Schoenen FJ, Wang J, Rogers S, Broward M, Bruns T, Anant S, Dixon DA, Meyer F, Chastain KM, Thamm DH, et al. Abstract 2903: A novel compound induces synthetic lethality for p53 mutations in osteosarcoma cells Cancer Research. 78: 2903-2903. DOI: 10.1158/1538-7445.Am2018-2903 |
0.338 |
|
| 2018 |
Schultz CW, O'Hayer K, Dhir T, Bolaji O, Bormes KM, Brown SZ, Thomsett H, Chand S, Jain A, Jiang W, McCarthy G, Yeo CJ, Goetz A, Nevler A, Brody JR, ... ... Dixon D, et al. Abstract 1961: Gaps in the armor: Targeting HuR to sensitize pancreatic cancer Cancer Research. 78: 1961-1961. DOI: 10.1158/1538-7445.Am2018-1961 |
0.405 |
|
| 2018 |
Vishwakarma V, Sanduja S, Zhuang S, Preet R, Dixon DA. 832 - The RNA-Binding Protein Tristetraprolin Controls Intestinal Cell Differentiation and Bacterial Symbiosis Through the Notch Signaling Pathway Gastroenterology. 154: S-173. DOI: 10.1016/S0016-5085(18)30990-9 |
0.699 |
|
| 2018 |
Preet R, Hung W, Vishwakarma V, Christenson L, Dixon DA. 733 - The RNA Binding Protein HUR Regulates Extracellular Vesicle Secretion in Colorectal Cancer Gastroenterology. 154: S-151-S-152. DOI: 10.1016/S0016-5085(18)30923-5 |
0.452 |
|
| 2017 |
Peng W, Furuuchi N, Aslanukova L, Huang YH, Brown SZ, Jiang W, Addya S, Vishwakarma V, Peters E, Brody JR, Dixon DA, Sawicki JA. Elevated HuR in Pancreas Promotes a Pancreatitis-like Inflammatory Microenvironment that Facilitates Tumor Development. Molecular and Cellular Biology. PMID 29133460 DOI: 10.1128/Mcb.00427-17 |
0.421 |
|
| 2017 |
Lal P, Cerofolini L, D'Agostino VG, Zucal C, Fuccio C, Bonomo I, Dassi E, Giuntini S, Di Maio D, Vishwakarma V, Preet R, Williams SN, Fairlamb MS, Munk R, Lehrmann E, ... ... Dixon DA, et al. Regulation of HuR structure and function by dihydrotanshinone-I. Nucleic Acids Research. 45: 9514-9527. PMID 28934484 DOI: 10.1093/Nar/Gkx623 |
0.415 |
|
| 2017 |
Lal S, Cheung EC, Zarei M, Preet R, Chand SN, Mambelli-Lisboa NC, Romeo C, Stout MC, Londin E, Goetz A, Lowder CY, Nevler A, Yeo CJ, Campbell PM, Winter JM, ... Dixon DA, et al. CRISPR Knockout of the HuR Gene Causes a Xenograft Lethal Phenotype. Molecular Cancer Research : McR. PMID 28242812 DOI: 10.1158/1541-7786.Mcr-16-0361 |
0.489 |
|
| 2017 |
Wu X, Marquez R, Han S, Lan L, Dixon DA, Aubé J, Welch DR, Xu L. Abstract 1145: Overcoming chemoresistance and blocking metastasis in breast cancer by targeting HuR Cancer Research. 77: 1145-1145. DOI: 10.1158/1538-7445.Am2017-1145 |
0.302 |
|
| 2017 |
Williams KN, Andres SF, Preet R, Hamilton KE, Chatterji P, Mizuno R, Dixon DA, Rustgi AK. Insulin-Like Growth Factor 2 mRNA Binding Protein 1 (IMP1) Enhances Exosome Generation in Colorectal Cancer Gastroenterology. 152. DOI: 10.1016/S0016-5085(17)30695-9 |
0.414 |
|
| 2016 |
Blanco FF, Preet R, Aguado A, Vishwakarma V, Stevens LE, Vyas A, Padhye S, Xu L, Weir SJ, Anant S, Meisner-Kober N, Brody JR, Dixon DA. Impact of HuR inhibition by the small molecule MS-444 on colorectal cancer cell tumorigenesis. Oncotarget. PMID 27677075 DOI: 10.18632/Oncotarget.12189 |
0.695 |
|
| 2016 |
Ahmed I, Roy BC, Subramaniam D, Ganie SA, Kwatra D, Dixon D, Anant S, Zargar MA, Umar S. An ornamental plant targets epigenetic signaling to block cancer stem cell-driven colon carcinogenesis. Carcinogenesis. PMID 26785732 DOI: 10.1093/Carcin/Bgw009 |
0.375 |
|
| 2016 |
Aguado A, Fischer T, Rodríguez C, Manea A, Martínez-González J, Touyz RM, Hernanz R, Alonso MJ, Dixon DA, Briones AM, Salaices M. Hu antigen R is required for NOX-1 but not NOX-4 regulation by inflammatory stimuli in vascular smooth muscle cells. Journal of Hypertension. 34: 253-65. PMID 26682942 DOI: 10.1097/Hjh.0000000000000801 |
0.368 |
|
| 2016 |
Preet R, Zhuang S, Hung W, Christenson LK, Dixon DA. Abstract A41: The RNA binding protein HuR enhances exosome secretion in colorectal cancer Cancer Research. 76: 5104-5104. DOI: 10.1158/1538-7445.Tme16-A41 |
0.487 |
|
| 2016 |
Wu X, Marquez RT, Han S, Li K, Lan L, Guo Y, Dixon DA, Aubé J, Welch DR, Xu L. Abstract 4832: Overcoming breast cancer chemoresistance and blocking metastasis by targeting RNA-binding protein HuR Cancer Research. 76: 4832-4832. DOI: 10.1158/1538-7445.Am2016-4832 |
0.41 |
|
| 2016 |
Preet R, Zhuang S, Hung W, Christenson L, Dixon DA. 105 The RNA Binding Protein HuR Enhances Exosome Secretion in Colorectal Cancer Gastroenterology. 150: S27. DOI: 10.1016/S0016-5085(16)30216-5 |
0.426 |
|
| 2015 |
Sobolewski C, Sanduja S, Blanco FF, Hu L, Dixon DA. Histone Deacetylase Inhibitors Activate Tristetraprolin Expression through Induction of Early Growth Response Protein 1 (EGR1) in Colorectal Cancer Cells. Biomolecules. 5: 2035-55. PMID 26343742 DOI: 10.3390/biom5032035 |
0.8 |
|
| 2015 |
Venugopal A, Subramaniam D, Balmaceda J, Roy B, Dixon DA, Umar S, Weir SJ, Anant S. RNA binding protein RBM3 increases β-catenin signaling to increase stem cell characteristics in colorectal cancer cells. Molecular Carcinogenesis. PMID 26331352 DOI: 10.1002/Mc.22404 |
0.448 |
|
| 2015 |
Di Francesco L, Dovizio M, Trenti A, Marcantoni E, Moore A, O Gaora P, McCarthy C, Tacconelli S, Bruno A, Alberti S, Gizzo S, Nardelli GB, Orso G, Belton O, Trevisi L, ... Dixon DA, et al. Dysregulated post-transcriptional control of COX-2 gene expression in gestational diabetic endothelial cells. British Journal of Pharmacology. PMID 26140661 DOI: 10.1111/Bph.13241 |
0.602 |
|
| 2015 |
Piasecka-Srader J, Blanco FF, Delman DH, Dixon DA, Geiser JL, Ciereszko RE, Petroff BK. Tamoxifen prevents apoptosis and follicle loss from cyclophosphamide in cultured rat ovaries. Biology of Reproduction. 92: 132. PMID 25833159 DOI: 10.1095/Biolreprod.114.126136 |
0.618 |
|
| 2015 |
Wu X, Lan L, Wilson DM, Marquez RT, Tsao WC, Gao P, Roy A, Turner BA, McDonald P, Tunge JA, Rogers SA, Dixon DA, Aubé J, Xu L. Identification and Validation of Novel Small Molecule Disruptors of HuR-mRNA Interaction. Acs Chemical Biology. 10: 1476-84. PMID 25750985 DOI: 10.1021/Cb500851U |
0.492 |
|
| 2015 |
Aguado A, Rodríguez C, Martínez-Revelles S, Avendaño MS, Zhenyukh O, Orriols M, Martínez-González J, Alonso MJ, Briones AM, Dixon DA, Salaices M. HuR mediates the synergistic effects of angiotensin II and IL-1β on vascular COX-2 expression and cell migration. British Journal of Pharmacology. 172: 3028-42. PMID 25653183 DOI: 10.1111/Bph.13103 |
0.349 |
|
| 2015 |
Subramaniam D, Ponnurangam S, Sayed A, Dhar A, Dixon DA, Tawfik O, Parab RR, Mishra PD, Ranadive P, Sharma R, Mahajan G, Sugumar A, Weir SJ, Jensen RA, Balakrishnan A, et al. Abstract 4214: Quinomycin A affects pancreatic cancer stem cells in part through suppression of notch signaling pathway Cancer Research. 75: 4214-4214. DOI: 10.1158/1538-7445.Am2015-4214 |
0.42 |
|
| 2015 |
Wu X, Lan L, Smith A, Marquez R, Wilson D, Rogers S, Gao P, Lovell S, Karanicolas J, Dixon D, Aubé J, Xu L. Abstract 2449: Targeting an “undruggable” RNA-binding protein: Discovery of small molecule inhibitors of HuR for novel breast cancer therapy Cancer Research. 75: 2449-2449. DOI: 10.1158/1538-7445.Am2015-2449 |
0.477 |
|
| 2015 |
Zhuang S, Hu L, Sanduja S, Umar S, Anant S, Dixon DA. Abstract 2130: The RNA-binding protein tristetraprolin controls intestinal cell differentiation and tumorigenesis through the Notch signaling pathway Cancer Research. 75: 2130-2130. DOI: 10.1158/1538-7445.Am2015-2130 |
0.767 |
|
| 2015 |
Subramaniam D, Ponnurangam S, Kwatra D, Kaushik G, Ramamoorthy P, Ramalingam S, Tawfik O, Weir SJ, Padhye S, Dixon DA, Umar S, Jensen RA, Anant S. Abstract 1893: Honokiol prevents colonic tumorigenesis and affects stem cell viability by affecting oncogenic YAP1 function Cancer Research. 75: 1893-1893. DOI: 10.1158/1538-7445.Am2015-1893 |
0.422 |
|
| 2015 |
Ahmed I, Roy B, Subramaniam D, Kwatra D, Weir SJ, Dixon DA, Anant S, Umar S. Sa1829 Phytochemicals Target Epigenetic Signaling to Block Cancer Stem Cell-Driven Colon Carcinogenesis Gastroenterology. 148: S-343. DOI: 10.1016/S0016-5085(15)31144-6 |
0.419 |
|
| 2015 |
Zhuang S, Hu L, Sanduja S, Umar S, Anant S, Dixon DA. 174 The RNA-Binding Protein Tristetraprolin Controls Intestinal Cell Differentiation and Tumorigenesis Through the Notch Pathway Gastroenterology. 148: S-47. DOI: 10.1016/S0016-5085(15)30163-3 |
0.724 |
|
| 2014 |
Blanco FF, Sanduja S, Deane NG, Blackshear PJ, Dixon DA. Transforming growth factor β regulates P-body formation through induction of the mRNA decay factor tristetraprolin. Molecular and Cellular Biology. 34: 180-95. PMID 24190969 DOI: 10.1128/Mcb.01020-13 |
0.752 |
|
| 2014 |
Martinez AA, Zhenyukh O, Fischer T, Rodriguez C, Martinez J, Revelles SM, Aras R, Dixon D, Briones AM, Salaices M. P719Different regulation of vascular NOX-1 and NOX-4 expression by interleukin-1beta and angiotensin II Cardiovascular Research. 103. DOI: 10.1093/Cvr/Cvu098.141 |
0.344 |
|
| 2014 |
Martinez AA, Zhenyukh O, Rodriguez C, Martinez J, Avendanno MS, Redondo LG, Alonso MJ, Briones AM, Dixon D, Salaices M. P717HuR mediate the sinergistic effects of Angiotensin II and interleukin 1beta on vascular COX-2 expression and cell migration Cardiovascular Research. 103. DOI: 10.1093/Cvr/Cvu098.139 |
0.353 |
|
| 2013 |
Upadhyay R, Sanduja S, Kaza V, Dixon DA. Genetic polymorphisms in RNA binding proteins contribute to breast cancer survival. International Journal of Cancer. Journal International Du Cancer. 132: E128-38. PMID 22907529 DOI: 10.1002/Ijc.27789 |
0.705 |
|
| 2013 |
Dixon DA, Blanco FF, Bruno A, Patrignani P. Mechanistic aspects of COX-2 expression in colorectal neoplasia. Recent Results in Cancer Research. Fortschritte Der Krebsforschung. ProgrèS Dans Les Recherches Sur Le Cancer. 191: 7-37. PMID 22893198 DOI: 10.1007/978-3-642-30331-9_2 |
0.736 |
|
| 2013 |
Blanco FF, Li Y, Meisner-Kober N, Anant S, Dixon DA. Abstract C38: Small molecule targeting of the mRNA stability factor HuR impacts COX-2 expression in colon cancer Cancer Prevention Research. 6. DOI: 10.1158/1940-6215.Prev-13-C38 |
0.705 |
|
| 2013 |
Blanco FF, Dixon DA. 680 TGF-β Is a Central Mediator of mRNA Decay Dynamics in Colorectal Cancer Gastroenterology. 144: S-124. DOI: 10.1016/S0016-5085(13)60447-3 |
0.643 |
|
| 2012 |
Rounbehler RJ, Fallahi M, Yang C, Steeves MA, Li W, Doherty JR, Schaub FX, Sanduja S, Dixon DA, Blackshear PJ, Cleveland JL. Tristetraprolin impairs myc-induced lymphoma and abolishes the malignant state. Cell. 150: 563-74. PMID 22863009 DOI: 10.1016/J.Cell.2012.06.033 |
0.745 |
|
| 2012 |
Dovizio M, Tacconelli S, Ricciotti E, Bruno A, Maier TJ, Anzellotti P, Di Francesco L, Sala P, Signoroni S, Bertario L, Dixon DA, Lawson JA, Steinhilber D, FitzGerald GA, Patrignani P. Effects of celecoxib on prostanoid biosynthesis and circulating angiogenesis proteins in familial adenomatous polyposis. The Journal of Pharmacology and Experimental Therapeutics. 341: 242-50. PMID 22262921 DOI: 10.1124/Jpet.111.190785 |
0.314 |
|
| 2012 |
Sanduja S, Blanco FF, Young LE, Kaza V, Dixon DA. The role of tristetraprolin in cancer and inflammation. Frontiers in Bioscience (Landmark Edition). 17: 174-88. PMID 22201737 DOI: 10.2741/3920 |
0.81 |
|
| 2012 |
Young LE, Moore AE, Sokol L, Meisner-Kober N, Dixon DA. The mRNA stability factor HuR inhibits microRNA-16 targeting of COX-2. Molecular Cancer Research : McR. 10: 167-80. PMID 22049153 DOI: 10.1158/1541-7786.Mcr-11-0337 |
0.638 |
|
| 2012 |
Moore AE, Young LE, Dixon DA. A common single-nucleotide polymorphism in cyclooxygenase-2 disrupts microRNA-mediated regulation. Oncogene. 31: 1592-8. PMID 21822307 DOI: 10.1038/Onc.2011.349 |
0.651 |
|
| 2012 |
Dixon DA. Post-transcriptional gene regulation in colorectal cancer Journal of Cancer Science & Therapy. DOI: 10.4172/1948-5956.S1.020 |
0.438 |
|
| 2012 |
Moore AE, Young LE, Weiler J, Meisner-Kober N, Dixon DA. Abstract 2949: miR-16 is an in vivo suppressor of gastrointestinal tumorigenesis Cancer Research. 72: 2949-2949. DOI: 10.1158/1538-7445.Am2012-2949 |
0.639 |
|
| 2012 |
Pineda D, Norris Z, Winter J, Dixon D, Witkiewicz A, Yeo C, Brody J. Tristetraprolin (TTP) Has Tumor Suppressor Characteristics in Pancreatic Cancer Cells and Can Regulate Gemcitabine Efficacy Journal of Surgical Research. 172: 341. DOI: 10.1016/J.Jss.2011.11.712 |
0.387 |
|
| 2011 |
Moore AE, Young LE, Dixon DA. MicroRNA and AU-rich element regulation of prostaglandin synthesis. Cancer Metastasis Reviews. 30: 419-35. PMID 22005950 DOI: 10.1007/S10555-011-9300-5 |
0.681 |
|
| 2011 |
Sanduja S, Blanco FF, Dixon DA. The roles of TTP and BRF proteins in regulated mRNA decay. Wiley Interdisciplinary Reviews. Rna. 2: 42-57. PMID 21278925 DOI: 10.1002/Wrna.28 |
0.805 |
|
| 2011 |
Blanco FF, Meisner N, Dixon DA. Abstract 5416: The low-molecular-weight compound MS-444 selectively targets cancer cells via inhibition of the mRNA stability factor HuR Cancer Research. 71: 5416-5416. DOI: 10.1158/1538-7445.Am2011-5416 |
0.711 |
|
| 2011 |
Young LE, Dixon DA. Abstract 3083: The RNA stability factor HuR promotes an angiogenic switch in colon cancer Cancer Research. 71: 3083-3083. DOI: 10.1158/1538-7445.Am2011-3083 |
0.509 |
|
| 2010 |
Sanduja S, Dixon DA. Tristetraprolin and E6-AP: Killing the messenger in cervical cancer. Cell Cycle (Georgetown, Tex.). 9: 3135-6. PMID 20865819 DOI: 10.4161/Cc.9.16.12951 |
0.704 |
|
| 2010 |
Young LE, Dixon DA. Posttranscriptional Regulation of Cyclooxygenase 2 Expression in Colorectal Cancer. Current Colorectal Cancer Reports. 6: 60-67. PMID 20577575 DOI: 10.1007/S11888-010-0044-3 |
0.564 |
|
| 2010 |
Sanduja S, Kaza V, Dixon DA. Abstract 3204: The mRNA decay factor tristetraprolin (TTP) induces senescence in human papillomavirus-transformed cervical cancer cells by targeting E6-AP ubiquitin ligase Cancer Research. 70: 3204-3204. DOI: 10.1158/1538-7445.Am10-3204 |
0.742 |
|
| 2010 |
Blanco FF, Sanduja S, Young L, Dixon D. Abstract 1225: Regulation of ARE-mediated mRNA decay during colorectal tumorigenesis Cellular and Molecular Biology. 70: 1225-1225. DOI: 10.1158/1538-7445.Am10-1225 |
0.783 |
|
| 2010 |
Moore AE, Dixon DA. T2016 Regulation of COX-2 Expression by MicroRNA-542-3p Gastroenterology. 138: S-613-S-614. DOI: 10.1016/S0016-5085(10)62829-6 |
0.584 |
|
| 2009 |
Sanduja S, Kaza V, Dixon DA. The mRNA decay factor tristetraprolin (TTP) induces senescence in human papillomavirus-transformed cervical cancer cells by targeting E6-AP ubiquitin ligase. Aging. 1: 803-17. PMID 20157568 |
0.734 |
|
| 2009 |
Young LE, Sanduja S, Bemis-Standoli K, Pena EA, Price RL, Dixon DA. The mRNA binding proteins HuR and tristetraprolin regulate cyclooxygenase 2 expression during colon carcinogenesis. Gastroenterology. 136: 1669-79. PMID 19208339 DOI: 10.1053/J.Gastro.2009.01.010 |
0.776 |
|
| 2009 |
Blanco FF, Young LE, Kanies CL, Beauchamp RD, Dixon DA. T1999 Regulation of Rapid mRNA Decay During Colon Tumorigenesis Gastroenterology. 136: A-617. DOI: 10.1016/S0016-5085(09)62845-6 |
0.641 |
|
| 2008 |
Kanies CL, Smith JJ, Kis C, Schmidt C, Levy S, Khabar KS, Morrow J, Deane N, Dixon DA, Beauchamp RD. Oncogenic Ras and transforming growth factor-beta synergistically regulate AU-rich element-containing mRNAs during epithelial to mesenchymal transition. Molecular Cancer Research : McR. 6: 1124-36. PMID 18644977 DOI: 10.1158/1541-7786.Mcr-07-2095 |
0.446 |
|
| 2008 |
Young LE, Moore AE, Dixon DA. 429 MicroRNA Control of COX-2 Expression Gastroenterology. 134: A-61-A-62. DOI: 10.1016/S0016-5085(08)60291-7 |
0.588 |
|
| 2007 |
Cao Z, Liu LZ, Dixon DA, Zheng JZ, Chandran B, Jiang BH. Insulin-like growth factor-I induces cyclooxygenase-2 expression via PI3K, MAPK and PKC signaling pathways in human ovarian cancer cells. Cellular Signalling. 19: 1542-53. PMID 17341442 DOI: 10.1016/J.Cellsig.2007.01.028 |
0.483 |
|
| 2007 |
Gong Z, Hebert JR, Bostick RM, Deng Z, Hurley TG, Dixon DA, Nitcheva D, Xie D. Common polymorphisms in 5-lipoxygenase and 12-lipoxygenase genes and the risk of incident, sporadic colorectal adenoma. Cancer. 109: 849-57. PMID 17236225 DOI: 10.1002/Cncr.22469 |
0.307 |
|
| 2006 |
Dixon DA, Tolley ND, Bemis-Standoli K, Martinez ML, Weyrich AS, Morrow JD, Prescott SM, Zimmerman GA. Expression of COX-2 in platelet-monocyte interactions occurs via combinatorial regulation involving adhesion and cytokine signaling. The Journal of Clinical Investigation. 116: 2727-38. PMID 16998585 DOI: 10.1172/Jci27209 |
0.436 |
|
| 2006 |
Shiou SR, Datta PK, Dhawan P, Law BK, Yingling JM, Dixon DA, Beauchamp RD. Smad4-dependent regulation of urokinase plasminogen activator secretion and RNA stability associated with invasiveness by autocrine and paracrine transforming growth factor-beta. The Journal of Biological Chemistry. 281: 33971-81. PMID 16959768 DOI: 10.1074/Jbc.M607010200 |
0.396 |
|
| 2006 |
Peng G, Dixon DA, Muga SJ, Smith TJ, Wargovich MJ. Green tea polyphenol (-)-epigallocatechin-3-gallate inhibits cyclooxygenase-2 expression in colon carcinogenesis. Molecular Carcinogenesis. 45: 309-19. PMID 16508969 DOI: 10.1002/Mc.20166 |
0.48 |
|
| 2006 |
Thiel A, Heinonen M, Rintahaka J, Hallikainen T, Hemmes A, Dixon DA, Haglund C, Ristimäki A. Expression of cyclooxygenase-2 is regulated by glycogen synthase kinase-3beta in gastric cancer cells. The Journal of Biological Chemistry. 281: 4564-9. PMID 16371352 DOI: 10.1074/Jbc.M512722200 |
0.439 |
|
| 2006 |
Peng G, Wargovich MJ, Dixon DA. Anti-proliferative effects of green tea polyphenol EGCG on Ha-Ras-induced transformation of intestinal epithelial cells. Cancer Letters. 238: 260-70. PMID 16157446 DOI: 10.1016/J.Canlet.2005.07.018 |
0.326 |
|
| 2005 |
Ying L, Marino J, Hussain SP, Khan MA, You S, Hofseth AB, Trivers GE, Dixon DA, Harris CC, Hofseth LJ. Chronic inflammation promotes retinoblastoma protein hyperphosphorylation and E2F1 activation. Cancer Research. 65: 9132-6. PMID 16230367 DOI: 10.1158/0008-5472.Can-05-1358 |
0.381 |
|
| 2005 |
Weyrich AS, Denis MM, Kuhlmann-Eyre JR, Spencer ED, Dixon DA, Marathe GK, McIntyre TM, Zimmerman GA, Prescott SM. Dipyridamole selectively inhibits inflammatory gene expression in platelet-monocyte aggregates. Circulation. 111: 633-42. PMID 15668340 DOI: 10.1161/01.Cir.0000154607.90506.45 |
0.358 |
|
| 2004 |
Weyrich AS, Lindemann S, Tolley ND, Kraiss LW, Dixon DA, Mahoney TM, Prescott SP, McIntyre TM, Zimmerman GA. Change in protein phenotype without a nucleus: translational control in platelets. Seminars in Thrombosis and Hemostasis. 30: 491-8. PMID 15354270 DOI: 10.1055/S-2004-833484 |
0.428 |
|
| 2004 |
Dixon DA. Dysregulated post-transcriptional control of COX-2 gene expression in cancer. Current Pharmaceutical Design. 10: 635-46. PMID 14965326 DOI: 10.2174/1381612043453171 |
0.535 |
|
| 2003 |
Parker MA, Deane NG, Thompson EA, Whitehead RH, Mithani SK, Washington MK, Datta PK, Dixon DA, Beauchamp RD. Over-expression of cyclin D1 regulates Cdk4 protein synthesis. Cell Proliferation. 36: 347-60. PMID 14710852 DOI: 10.1046/J.1365-2184.2003.00290.X |
0.388 |
|
| 2003 |
Dixon DA, Balch GC, Kedersha N, Anderson P, Zimmerman GA, Beauchamp RD, Prescott SM. Regulation of cyclooxygenase-2 expression by the translational silencer TIA-1. The Journal of Experimental Medicine. 198: 475-81. PMID 12885872 DOI: 10.1084/Jem.20030616 |
0.549 |
|
| 2003 |
Subbaramaiah K, Marmo TP, Dixon DA, Dannenberg AJ. Regulation of cyclooxgenase-2 mRNA stability by taxanes: evidence for involvement of p38, MAPKAPK-2, and HuR. The Journal of Biological Chemistry. 278: 37637-47. PMID 12826679 DOI: 10.1074/Jbc.M301481200 |
0.48 |
|
| 2003 |
Dixon DA. Regulation of COX-2 expression in human cancers. Progress in Experimental Tumor Research. 37: 52-71. PMID 12795048 DOI: 10.1159/000071363 |
0.432 |
|
| 2003 |
Boutaud O, Dixon DA, Oates JA, Sawaoka H. Tristetraprolin binds to the COX-2 mRNA 3' untranslated region in cancer cells. Advances in Experimental Medicine and Biology. 525: 157-60. PMID 12751757 DOI: 10.1007/978-1-4419-9194-2_32 |
0.548 |
|
| 2003 |
Sawaoka H, Dixon DA, Oates JA, Boutaud O. Tristetraprolin binds to the 3'-untranslated region of cyclooxygenase-2 mRNA. A polyadenylation variant in a cancer cell line lacks the binding site. The Journal of Biological Chemistry. 278: 13928-35. PMID 12578839 DOI: 10.1074/Jbc.M300016200 |
0.477 |
|
| 2003 |
Kraiss LW, Alto NM, Dixon DA, McIntyre TM, Weyrich AS, Zimmerman GA. Fluid flow regulates E-selectin protein levels in human endothelial cells by inhibiting translation. Journal of Vascular Surgery. 37: 161-8. PMID 12514595 DOI: 10.1067/Mva.2003.67 |
0.319 |
|
| 2001 |
Dixon DA, Tolley ND, King PH, Nabors LB, McIntyre TM, Zimmerman GA, Prescott SM. Altered expression of the mRNA stability factor HuR promotes cyclooxygenase-2 expression in colon cancer cells. The Journal of Clinical Investigation. 108: 1657-65. PMID 11733561 DOI: 10.1172/Jci12973 |
0.534 |
|
| 2001 |
Mahoney TS, Weyrich AS, Dixon DA, McIntyre T, Prescott SM, Zimmerman GA. Cell adhesion regulates gene expression at translational checkpoints in human myeloid leukocytes. Proceedings of the National Academy of Sciences of the United States of America. 98: 10284-9. PMID 11517314 DOI: 10.1073/Pnas.181201398 |
0.449 |
|
| 2001 |
Lindemann S, Tolley ND, Dixon DA, McIntyre TM, Prescott SM, Zimmerman GA, Weyrich AS. Activated platelets mediate inflammatory signaling by regulated interleukin 1beta synthesis. The Journal of Cell Biology. 154: 485-90. PMID 11489912 DOI: 10.1083/Jcb.200105058 |
0.303 |
|
| 2000 |
Kraiss LW, Weyrich AS, Alto NM, Dixon DA, Ennis TM, Modur V, McIntyre TM, Prescott SM, Zimmerman GA. Fluid flow activates a regulator of translation, p70/p85 S6 kinase, in human endothelial cells. American Journal of Physiology. Heart and Circulatory Physiology. 278: H1537-44. PMID 10775131 DOI: 10.1152/Ajpheart.2000.278.5.H1537 |
0.374 |
|
| 2000 |
Dixon DA, Kaplan CD, McIntyre TM, Zimmerman GA, Prescott SM. Post-transcriptional control of cyclooxygenase-2 gene expression. The role of the 3'-untranslated region. The Journal of Biological Chemistry. 275: 11750-7. PMID 10766797 DOI: 10.1074/Jbc.275.16.11750 |
0.533 |
|
| 2000 |
Sheng H, Shao J, Dixon DA, Williams CS, Prescott SM, DuBois RN, Beauchamp RD. Transforming growth factor-beta1 enhances Ha-ras-induced expression of cyclooxygenase-2 in intestinal epithelial cells via stabilization of mRNA. The Journal of Biological Chemistry. 275: 6628-35. PMID 10692471 DOI: 10.1074/Jbc.275.9.6628 |
0.35 |
|
| 1999 |
Pabla R, Weyrich AS, Dixon DA, Bray PF, McIntyre TM, Prescott SM, Zimmerman GA. Integrin-dependent control of translation: engagement of integrin alphaIIbbeta3 regulates synthesis of proteins in activated human platelets. The Journal of Cell Biology. 144: 175-84. PMID 9885253 DOI: 10.1083/Jcb.144.1.175 |
0.412 |
|
| 1998 |
Weyrich AS, Dixon DA, Pabla R, Elstad MR, McIntyre TM, Prescott SM, Zimmerman GA. Signal-dependent translation of a regulatory protein, Bcl-3, in activated human platelets. Proceedings of the National Academy of Sciences of the United States of America. 95: 5556-61. PMID 9576921 DOI: 10.1073/Pnas.95.10.5556 |
0.371 |
|
| 1998 |
Dixon DA, Murphy KJ, Prescott SM. Defective control of protein synthesis in colon cancer cells results in constitutive expression of cyclooxygenase-2 protein Gastroenterology. 114: A585. DOI: 10.1016/S0016-5085(98)82381-0 |
0.424 |
|
| 1996 |
Dixon DA. Altered molecular regulation of prostaglandin h synthase 2 in cancer cells Faseb Journal. 10. |
0.42 |
|
| Show low-probability matches. |